Packaging Corp of America said on Tuesday it would buy the containerboard business of peer Greif for $1.8 billion, aimed at increasing its capacity for the material used to ship consumer goods and ...

Custom corrugated packaging solutions manufacturer Golden West Packaging Group has announced the successful amendment of its credit facilities, a move designed to bolster the company's growth and ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.

Generation Food Rural Partners I (GFRP) has announced the merger of TerraSafe Materials and DisSolves, aimed at bridging the technology gap between packaging materials and films.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

In addition, Novo Nordisk said it has filed for a label expansion for Rybelsus with the EMA and FDA. This could potentially make Rybelsus the first and only oral GLP-1 RA with proven ...

Nation and World Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 20, 2025, 11:05 a.m.

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Gummy vitamins are being recalled for an issue with the packaging, which can cause a severe or life-threatening reaction, according to the U.S. Food and Drug Administration. (Courtesy of U.S. Food ...